BC Week In Review | Feb 24, 2014
Clinical News

Bisantrene regulatory update

Update said FDA granted Orphan Drug designation to UPI-928 to treat acute myelogenous leukemia (AML). Update said it is preparing an IND submission for the small molecule anthracene derivative. The product was approved as Zantrene...
Items per page:
1 - 1 of 1